<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The most common genetic alteration identified in transitional cell <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:chebi fb="15" ids="48347">TCC</z:chebi>) of the bladder is loss of heterozygosity (LOH) on chromosome 9 </plain></SENT>
<SENT sid="1" pm="."><plain>However, localization of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes on 9q has been hampered by the low frequency of subchromosomal deletions </plain></SENT>
<SENT sid="2" pm="."><plain>We have analysed 139 primary, initial low stage <z:chebi fb="15" ids="48347">TCC</z:chebi> of the bladder using a panel of 28 microsatellite markers spanning chromosome 9 at an average distance of 5 Mb, following a primer-extension preamplification (PEP) technique </plain></SENT>
<SENT sid="3" pm="."><plain>Sixty-seven (48%) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> showed LOH at one or more loci and partial deletions were detected in 62 (45%) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>; apparent <z:mp ids='MP_0004026'>monosomy</z:mp> 9 was detected in only five (4%) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Deletions were more frequent on 9q (44%) than on 9p (23%), the latter being mostly associated with 9q deletion, suggesting that alteration of genes on 9q may be an early event associated with superficial <z:e sem="disease" ids="C0476073" disease_type="Neoplastic Process" abbrv="">papillary tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Combined data from the cases with partial 9q deletions displayed four candidate regions for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor loci, based on the frequency of deletion observed and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with unique deletions at these sites </plain></SENT>
<SENT sid="6" pm="."><plain>In two <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, the unique partial deletion comprised D9S12 at 9q22.3, a region encompassing loci for the <z:e sem="disease" ids="C0004779,C0812437" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">Gorlin syndrome</z:e> and multiple self-healing squamous <z:e sem="disease" ids="C0553707" disease_type="Neoplastic Process" abbrv="">epithelioma</z:e> gene </plain></SENT>
<SENT sid="7" pm="."><plain>In two other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, the single LOH was identified at the D9S172 locus at 9q31-32 where the dysautonia and Fukuyama-type <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> genes have been located </plain></SENT>
<SENT sid="8" pm="."><plain>One <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> showed unique LOH at the GSN locus at 9q33, a region frequently deleted in other <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> while the fourth region of deletion was observed at 9q34 between ASS and ABL-1, in two <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>This region is frequently deleted in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and encompasses the locus for the hereditary hemorrhagic <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> gene </plain></SENT>
<SENT sid="10" pm="."><plain>These findings suggest four target regions on 9q within which suppressor genes for <z:chebi fb="15" ids="48347">TCC</z:chebi> may reside </plain></SENT>
</text></document>